NCT07216950 · NOT YET RECRUITING

Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)

This trial tests a behavioral program called KINDER, designed to help family caregivers of people with dementia communicate better and reduce relationship strain — with the goal of preventing psychological abuse toward the person they care for. A Phase 2 trial means researchers are testing whether the program actually works, not just whether it is safe. A comparison group receives a general healthy-living program for caregivers instead.

Eligibility criteria

Inclusion Criteria:
* Age range: from 18 to No upper limit;
* Be a family member to an individual living with AD/ADRD;
* Provide assistance with at least two instrumental activities of daily living or one activity of daily living;
* Provides at least 4 hours of caregiving per day and sees the care recipient in-person at least 2 times per week on average
* The care recipient is at least age 65 or older
* Report an AD8 Dementia Screening score for care recipients of at least 2;
* Commit to attending at three discussion sessions;
* Have reliable access to internet and email, and to be able to attend synchronous sessions using the Zoom videoconferencing platform.
* Caregiver lives in any of the following states, which may require mandetory reporting of elder mistreatment when responding to survey questions:
Delaware, Florida, Indiana, Kentucky, Louisiana, Mississippi, Montana, New Hampshire, New Mexico, North Carolina, Oklahoma, Rhode Island, South Carolina, Tennessee, Texas, Utah, Wyoming
Exclusion Criteria:
* Are unable to read or speak English;
* Previously participated in Learning Skills Together (NCT05846984) or KINDER pilot study;
* Have plans to place the care recipient in a skilled nursing facility within the next 8 months (i.e., study duration)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-09-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials